{"@id":"https://bioecon.ru/technology/tcr-immune-receptor-therapies/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/tcr-immune-receptor-therapies/","json":"https://cn.bioecon.ru/api/v1/technology/tcr-immune-receptor-therapies/index.json"},"id":"tcr-immune-receptor-therapies","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/cryoport-systems/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/quantec-ltd/","https://bioecon.ru/companies/minicircle/","https://bioecon.ru/companies/anft-association-of-nature-forest-therapy/","https://bioecon.ru/companies/kheiron-biotech/","https://bioecon.ru/companies/pbs-biotech/","https://bioecon.ru/companies/retro-biosciences/"]},"maturity":7,"name":"特异性T细胞受体（TCR-T）与免疫受体调控疗法","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"胞内核心肿瘤抗原短肽高分辨质谱鉴定"},{"n":2,"title":"结构引导下的TCR亲和力生理级微调"},{"n":3,"title":"内源性TCR基因双位点精准敲除"},{"n":4,"title":"Coronin 1肌动蛋白骨架信号阻断"}],"summary":"通过工程化改造T细胞受体（TCR）α/β异二聚体的高亲和力结合环，特异性识别人白细胞抗原（HLA）呈递的胞内肿瘤核心癌蛋白短肽，结合Coronin 1信号网络调控实现移植物耐受与自免干预。","url":"/technology/tcr-immune-receptor-therapies/","verified":"2026-11-22"}